Literature DB >> 22079134

Innate and adaptive immunity in bacteria: mechanisms of programmed genetic variation to fight bacteriophages.

David Bikard1, Luciano A Marraffini.   

Abstract

Bacteria are constantly challenged by bacteriophages (viruses that infect bacteria), the most abundant microorganism on earth. Bacteria have evolved a variety of immunity mechanisms to resist bacteriophage infection. In response, bacteriophages can evolve counter-resistance mechanisms and launch a 'virus versus host' evolutionary arms race. In this context, rapid evolution is fundamental for the survival of the bacterial cell. Programmed genetic variation mechanisms at loci involved in immunity against bacteriophages generate diversity at a much faster rate than random point mutation and enable bacteria to quickly adapt and repel infection. Diversity-generating retroelements (DGRs) and phase variation mechanisms enhance the generic (innate) immune response against bacteriophages. On the other hand, the integration of small bacteriophage sequences in CRISPR loci provide bacteria with a virus-specific and sequence-specific adaptive immune response. Therefore, although using different molecular mechanisms, both prokaryotes and higher organisms rely on programmed genetic variation to increase genetic diversity and fight rapidly evolving infectious agents. Copyright Â
© 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22079134     DOI: 10.1016/j.coi.2011.10.005

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  39 in total

1.  BREX is a novel phage resistance system widespread in microbial genomes.

Authors:  Tamara Goldfarb; Hila Sberro; Eyal Weinstock; Ofir Cohen; Shany Doron; Yoav Charpak-Amikam; Shaked Afik; Gal Ofir; Rotem Sorek
Journal:  EMBO J       Date:  2014-12-01       Impact factor: 11.598

Review 2.  Mechanisms and consequences of diversity-generating immune strategies.

Authors:  Edze R Westra; David Sünderhauf; Mariann Landsberger; Angus Buckling
Journal:  Nat Rev Immunol       Date:  2017-08-07       Impact factor: 53.106

Review 3.  Evolutionary Ecology of Prokaryotic Immune Mechanisms.

Authors:  Stineke van Houte; Angus Buckling; Edze R Westra
Journal:  Microbiol Mol Biol Rev       Date:  2016-07-13       Impact factor: 11.056

4.  CRISPR-Cas9-Based Genome Editing of Human Induced Pluripotent Stem Cells.

Authors:  Joseph C Giacalone; Tasneem P Sharma; Erin R Burnight; John F Fingert; Robert F Mullins; Edwin M Stone; Budd A Tucker
Journal:  Curr Protoc Stem Cell Biol       Date:  2018-02-28

5.  Coagulase-negative staphylococci as reservoirs of genes facilitating MRSA infection: Staphylococcal commensal species such as Staphylococcus epidermidis are being recognized as important sources of genes promoting MRSA colonization and virulence.

Authors:  Michael Otto
Journal:  Bioessays       Date:  2012-11-19       Impact factor: 4.345

Review 6.  Evolution of the CRISPR-Cas adaptive immunity systems in prokaryotes: models and observations on virus-host coevolution.

Authors:  Eugene V Koonin; Yuri I Wolf
Journal:  Mol Biosyst       Date:  2014-09-19

Review 7.  Evolutionary Genomics of Defense Systems in Archaea and Bacteria.

Authors:  Eugene V Koonin; Kira S Makarova; Yuri I Wolf
Journal:  Annu Rev Microbiol       Date:  2017-06-28       Impact factor: 15.500

8.  Highly heterogeneous mutation rates in the hepatitis C virus genome.

Authors:  Ron Geller; Úrsula Estada; Joan B Peris; Iván Andreu; Juan-Vicente Bou; Raquel Garijo; José M Cuevas; Rosario Sabariegos; Antonio Mas; Rafael Sanjuán
Journal:  Nat Microbiol       Date:  2016-04-18       Impact factor: 17.745

Review 9.  Adapting to new threats: the generation of memory by CRISPR-Cas immune systems.

Authors:  Robert Heler; Luciano A Marraffini; David Bikard
Journal:  Mol Microbiol       Date:  2014-06-04       Impact factor: 3.501

10.  Fifty shades of immune defense.

Authors:  Michael F Criscitiello; Paul de Figueiredo
Journal:  PLoS Pathog       Date:  2013-02-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.